Clinical trial
Efavirenz for Patients With Alzheimer's Disease
NCT03706885
Study timeline
Study start (actual)2018-05-05Date precision: day
Registry last updated2023-02-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Disease, Early Onsetunresolved
Interventions
Sustiva PillDRUG
Sponsors & collaborators
Case Western Reserve Universitylead sponsor
University Hospitals Cleveland Medical Centercollaborator
Massachusetts General Hospitalcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03706885 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.